Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.48 |
| ▸ | PGK2 | P07205 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TPMT | P51580 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SELL | P14151 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
| ▸ | SELE | P16581 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | C1S | P09871 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL92965 | 0.94 | ACHE (0.48) | PGK1PGK2ACHEALDH1A1TPMT | |
| Methoxymethane SCHEMBL27768340 | 0.92 | PGK1 (0.43) | PGK1PGK2ACHEALDH1A1TPMT | |
| SCHEMBL25877374 | 0.92 | SHBG (0.45) | PGK1PGK2ACHEALDH1A1TPMT | |
| SCHEMBL16952582 | 0.89 | PGK1 (0.41) | PGK1PGK2ACHEALDH1A1TPMT | |
| SCHEMBL16956257 | 0.85 | PGK1 (0.39) | PGK1PGK2ACHEALDH1A1 | |
| Magnesium Chloride Anhydrous SCHEMBL28163486 | 0.84 | ACHE (0.40) | PGK1PGK2ACHEALDH1A1TPMT | |
| SCHEMBL31139273 | 0.84 | ACHE (0.67) | PGK1PGK2ACHEALDH1A1SELL | |
| SCHEMBL4848593 | 0.84 | ACHE (0.67) | PGK1PGK2ACHEALDH1A1SELL | |
| SCHEMBL14882643 | 0.83 | ESR1 (0.40) | PGK1PGK2ACHEALDH1A1TPMT | |
| SCHEMBL2904830 | 0.83 | ACHE (0.41) | PGK1PGK2ACHEALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025053791-A1 | ONE-POT GRAFTING OF POLYMERS FROM ALCOHOLS AND BIOMASSES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-03-13 | — | — | WO | claimed |
| EP-2548739-B1 | Lithographic printing plate precursor | FUJIFILM CORP (JP) | 2015-12-16 | — | — | EP | claimed |
| EP-2548739-A2 | Lithographic printing plate precursor | Fujifilm Corporation (JP) | 2013-01-23 | — | — | EP | claimed |
| WO-2025053791-A1 | ONE-POT GRAFTING OF POLYMERS FROM ALCOHOLS AND BIOMASSES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-03-13 | — | — | WO | disclosed |
| CN-118085228-A | Triazole curing material containing multiple hydrogen bonds and preparation method thereof | 碳衡(重庆)生物质新材料有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114341103-B | Aminoguanhydrazones as retrograde transport stabilizers useful in the treatment of neurological diseases | 圣拉斐尔医院有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-114341103-A | Aminoguanidinohydrazones as reverse transporter stabilizers useful for the treatment of neurological disorders | 圣拉斐尔医院有限公司 | 2022-04-12 | — | — | CN | disclosed |
| EP-3947344-A1 | AMINOGUANIDINE HYDRAZONES AS RETROMER STABILIZERS USEFUL FOR TREATING NEUROLOGICAL DISEASES | Ospedale San Raffaele Srl (IT) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020201326-A1 | AMINOGUANIDINE HYDRAZONES AS RETROMER STABILIZERS USEFUL FOR TREATING NEUROLOGICAL DISEASES | OSPEDALE SAN RAFFAELE SRL (IT) | 2020-10-08 | — | — | WO | disclosed |
| US-20200277406-A1 | BINDING AGENT | ROCHE DIAGNOSTICS GMBH (DE) | 2020-09-03 | — | — | US | disclosed |
| US-9890179-B2 | Methods of preparing cytotoxic benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2018-02-13 | — | — | US | disclosed |
| WO-2007093621-A1 | CYCLIC SULFONES USEFUL AS BACE INHIBITORS | NOVARTIS AG (CH) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007085930-A1 | CYTOTOXIC AGENTS COMPRISING NEW TOMAYMYCIN DERIVATIVES AND THEIR THERAPEUTIC USE | SANOFI-AVENTIS (FR) | 2007-08-02 | — | — | WO | disclosed |
| EP-1813614-A1 | Cytotoxic agents comprising new tomaymycin derivatives | Sanofi-Aventis (FR) | 2007-08-01 | — | — | EP | disclosed |
| US-6942955-B2 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2005-09-13 | — | — | US | disclosed |
| US-20040229153-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| US-6699638-B2 | ON A THERMAL CROSSLINKING LAYER A WATER SOLUBLE OVERCOAT LAYER, AND AT LEAST ONE OF THESE LAYERS CONTAINS A COMPOUND CAPABLE OF CONVERTING LIGHT INTO HEAT; EASY TO HANDLE AND CAUSES NO DEFECTS EVEN WHEN TOUCHED WITH FINGERS | FUJI PHOTO FILM CO., LTD. (JP) | 2004-03-02 | — | — | US | disclosed |
| US-6632580-B2 | Hydrophilic support; recording using infrared radiation scanning radiation | FUJI PHOTO FILM CO., LTD. (JP) | 2003-10-14 | — | — | US | disclosed |
| EP-1160083-A2 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2001-12-05 | — | — | EP | disclosed |
| US-20010031423-A1 | On a thermal crosslinking layer a water soluble overcoat layer, and at least one of these layers contains a compound capable of converting light into heat; easy to handle and causes no defects even when touched with fingers | FUJIFILM CORPORATION (JP) | 2001-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277406-A1 | BINDING AGENT | SSB, APBA1, SHBG | PGK1 4720/4885PGK2 4729/4885ACHE 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.